Kazia Therapeutics Announces The Filing Of Provisional Patent For Novel Strategy, Supported By Preclinical Data, To Prevent Metastatic Recurrence In Triple-Negative Breast Cancer
KZIA•Provisional patent filing
July 28 (Reuters) - Kazia Therapeutics Ltd $KZIA.O$:
- Kazia Therapeutics announces the filing of a provisional patent for a novel strategy, supported by preclinical data, to prevent metastatic recurrence in triple-negative breast cancer.
